Evidence map›Paper›PMID 19916796›Full record

ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2009

Universal antiretroviral therapy for pregnant and breast-feeding HIV-1-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings.

Renaud Becquet, Didier K Ekouevi, Elise Arrive, Jeffrey S A Stringer, Nicolas Meda, Marie-Laure Chaix, Jean-Marc Treluyer, Valériane Leroy, Christine Rouzioux, Stéphane Blanche and 1 more

Registry-linked trialAbstract readReview
In one paragraph

Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01061151 (Breastfeeding Version of the PROMISE Study), which is not on this map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01061151 phase3completednot on this mapstarted 2011, after this paper: background citation

Breastfeeding Version of the PROMISE Study (Promoting Maternal and Infant Survival Everywhere)

TypeinterventionalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2011 to 2016Enrolled3,747ConditionsHIV InfectionsArmsZidovudine (ZDV), Nevirapine (NVP): Antepartum Mothers, Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]) tail, Lamivudine-Zidovudine (3TC-ZDV), Lopinavir-ritonavir (LPV-RTV)
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Antiretroviral interventions for preventing breast milk transmission of HIV.The Cochrane database of systematic reviews · 2014
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Effect of vitamin supplements on HIV shedding in breast milk.The American journal of clinical nutrition · 2010
    Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Understanding HIV compartments and reservoirs.Current HIV/AIDS reports · 2014
    Review
  16. The impact of a HIV prevention of mother to child transmission program in a nigerian early infant diagnosis centre.Nigerian medical journal : journal of the Nigeria Medical Association · 2014
    Article
  17. Article
  18. Diagnosis and Management of Cryptococcal Relapse.Journal of AIDS & clinical research · 2013
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Renaud BecquetINSERM, Unité 897, Centre de Recherche Epidémiologie et Biostatistique, Bordeaux, France.
Didier K Ekouevi
Elise Arrive
Jeffrey S A Stringer
Nicolas Meda
Marie-Laure Chaix
Jean-Marc Treluyer
Valériane Leroy
Christine Rouzioux
Stéphane Blanche
François Dabis

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prevention of mother-to-child transmission (MTCT) of human immunodeficiency virus type 1 (HIV-1) remains a challenge in most resource-limited settings, particularly in Africa. Single-dose and short-course antiretroviral (ARV) regimens are only partially effective and have failed to achieve wide coverage despite their apparent simplicity. More potent ARV combinations are restricted to pregnant women who need treatment for themselves and are also infrequently used. Furthermore, postnatal transmission via breast-feeding is a serious additional threat. Modifications of infant feeding practices aim to reduce HIV-1 transmission through breast milk; replacement feeding is neither affordable nor safe for the majority of African women, and early breast-feeding cessation (eg, prior to 6 months of life) requires substantial care and nutritional counseling to be practiced safely. The recent roll out of ARV treatment has changed the paradigm of prevention of MTCT. To date, postnatal ARV interventions that have been evaluated target either maternal ARV treatment to selected breast-feeding women, with good efficacy, or single-drug postexposure prophylaxis for short periods of time to their neonates, with a partial efficacy and at the expense of acquisition of drug-related viral resistance. We hypothesize that a viable solution to eliminate pediatric AIDS lies in the universal provision of fully suppressive ARV regimens to all HIV-1-infected women through pregnancy, delivery, and the entire breast-feeding period. On the basis of available evidence, we suggest translating into practice the recently available evidence on this matter without any further delay.

Indexed as

Antiretroviral Therapy, Highly ActiveHIV-1Acquired Immunodeficiency SyndromeBreast FeedingCD4 Lymphocyte CountFemaleHealth ResourcesHumansInfectious Disease Transmission, VerticalPregnancyPregnancy Complications, Infectious

Identifiers

PMID19916796
PMCPMC3309024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.